FeesSafety
Pluang+

Satellogic and HEO extend non-Earth imaging deal with $1M+ annual commitment through 2029

Market News
29 Oct 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
Satellogic and HEO extend non-Earth imaging deal with $1M+ annual commitment through 2029

Satellogic and HEO have signed a three-year agreement through 2029, with a seven-figure minimum annual commitment, to continue providing high-resolution non-Earth imaging services. This deal builds on their six-year partnership that began in 2020 with imaging the International Space Station. HEO uses Satellogic's satellite constellation to capture and analyze objects in orbit, supporting global space domain awareness. The agreement includes access to Satellogic's latest satellites, enhancing HEO's ability to deliver timely and detailed space intelligence to government and defense clients.

Satellogic and HEO's new three-year non-Earth imaging agreement follows a six-year collaboration. For readers following Technology-sector US stocks on Pluang, here is the market snapshot as of Oct 29, 2026 18:11 WIB: out of 150 priced stocks, 23 rose and 125 fell. Notable movers include NOW (ServiceNow Inc) at USD 120.15 with a 1-day change of -19.97% and a typical hold time of 56 days, with Pluang order activity showing 93% Sell and 7% Buy, MRVL (Marvell Technology Inc) at USD 222.51 down 11.58%, and CTSH (Cognizant Technology Solutions Corp) at USD 58.93 down 11.20%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App